FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009588082> ?p ?o ?g. }

• W2009588082 endingPage "2060" @default.
• W2009588082 startingPage "2054" @default.
• W2009588082 abstract "The purpose of the current study was to evaluate the objective response rate and possibility of breast-conserving surgery using neoadjuvant tamoxifen in the multimodality treatment, including surgery and radiotherapy, of elderly or frail patients with locally advanced breast carcinoma.Forty-seven patients age > 75 years or age < 75 years with comorbid conditions and locally advanced breast carcinoma were treated with neoadjuvant tamoxifen (20 mg/day) for 3-6 months. This was followed by surgery and radiotherapy when feasible and adjuvant tamoxifen for 5 years or until disease recurrence.The median age of the patients was 72 years (range, 48-86 years). Approximately 22% had T3 lesions, 57% had T4 lesions, 22% were Stage II (AJCC Manual for Staging Cancer, 3rd edition), and 78% were Stage III. Eighty percent were estrogen receptor positive. After 6 months of treatment with neoadjuvant tamoxifen, a response rate of 47% was observed, including a complete response rate of 6%. Twenty-nine patients (62%) were rendered free of disease by surgery, including 5 with breast-conserving procedures. After a median follow-up of 40 months, 23 patients (49%) remained disease free. The median survival time had not been reached at the time of last follow-up. No major toxicity was observed, with the exception of one patient who developed a possible tamoxifen-related Stage I endometrial carcinoma. The estimated 2-year and 5-year progression free and overall survival rates were 50% and 41%, and 83% and 59%, respectively.The results of the current study show that neoadjuvant tamoxifen was effective in the treatment of elderly or frail patients with locally advanced breast carcinoma with estrogen receptor positive tumors, and resulted in a reasonable response rate, including complete responses and good overall survival." @default.
• W2009588082 created "2016-06-24" @default.
• W2009588082 creator A5006094760 @default.
• W2009588082 creator A5007108434 @default.
• W2009588082 creator A5010686398 @default.
• W2009588082 creator A5018617106 @default.
• W2009588082 creator A5026926354 @default.
• W2009588082 creator A5028916394 @default.
• W2009588082 creator A5045860204 @default.
• W2009588082 creator A5071158497 @default.
• W2009588082 creator A5072207853 @default.
• W2009588082 creator A5080832682 @default.
• W2009588082 date "2000-05-01" @default.
• W2009588082 modified "2023-10-12" @default.
• W2009588082 title "Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy" @default.
• W2009588082 cites W1262485082 @default.
• W2009588082 cites W1562190372 @default.
• W2009588082 cites W1788623134 @default.
• W2009588082 cites W1941013643 @default.
• W2009588082 cites W1964510050 @default.
• W2009588082 cites W1965660816 @default.
• W2009588082 cites W1988168341 @default.
• W2009588082 cites W1993249767 @default.
• W2009588082 cites W1995675713 @default.
• W2009588082 cites W1999571757 @default.
• W2009588082 cites W2003167490 @default.
• W2009588082 cites W2016599551 @default.
• W2009588082 cites W2018669222 @default.
• W2009588082 cites W2038321927 @default.
• W2009588082 cites W2042162210 @default.
• W2009588082 cites W2083973655 @default.
• W2009588082 cites W2130294911 @default.
• W2009588082 cites W2232616986 @default.
• W2009588082 cites W4231558142 @default.
• W2009588082 cites W4293241248 @default.
• W2009588082 doi "https://doi.org/10.1002/(sici)1097-0142(20000501)88:9<2054::aid-cncr11>3.0.co;2-j" @default.
• W2009588082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10813717" @default.
• W2009588082 hasPublicationYear "2000" @default.
• W2009588082 type Work @default.
• W2009588082 sameAs 2009588082 @default.
• W2009588082 citedByCount "37" @default.
• W2009588082 countsByYear W20095880822012 @default.
• W2009588082 countsByYear W20095880822013 @default.
• W2009588082 countsByYear W20095880822014 @default.
• W2009588082 countsByYear W20095880822016 @default.
• W2009588082 countsByYear W20095880822018 @default.
• W2009588082 countsByYear W20095880822021 @default.
• W2009588082 countsByYear W20095880822023 @default.
• W2009588082 crossrefType "journal-article" @default.
• W2009588082 hasAuthorship W2009588082A5006094760 @default.
• W2009588082 hasAuthorship W2009588082A5007108434 @default.
• W2009588082 hasAuthorship W2009588082A5010686398 @default.
• W2009588082 hasAuthorship W2009588082A5018617106 @default.
• W2009588082 hasAuthorship W2009588082A5026926354 @default.
• W2009588082 hasAuthorship W2009588082A5028916394 @default.
• W2009588082 hasAuthorship W2009588082A5045860204 @default.
• W2009588082 hasAuthorship W2009588082A5071158497 @default.
• W2009588082 hasAuthorship W2009588082A5072207853 @default.
• W2009588082 hasAuthorship W2009588082A5080832682 @default.
• W2009588082 hasConcept C121608353 @default.
• W2009588082 hasConcept C126322002 @default.
• W2009588082 hasConcept C141071460 @default.
• W2009588082 hasConcept C143998085 @default.
• W2009588082 hasConcept C146357865 @default.
• W2009588082 hasConcept C151730666 @default.
• W2009588082 hasConcept C2777176818 @default.
• W2009588082 hasConcept C2777546739 @default.
• W2009588082 hasConcept C2777757722 @default.
• W2009588082 hasConcept C2777982462 @default.
• W2009588082 hasConcept C2778292576 @default.
• W2009588082 hasConcept C2781467025 @default.
• W2009588082 hasConcept C3018521938 @default.
• W2009588082 hasConcept C509974204 @default.
• W2009588082 hasConcept C530470458 @default.
• W2009588082 hasConcept C71924100 @default.
• W2009588082 hasConcept C86803240 @default.
• W2009588082 hasConceptScore W2009588082C121608353 @default.
• W2009588082 hasConceptScore W2009588082C126322002 @default.
• W2009588082 hasConceptScore W2009588082C141071460 @default.
• W2009588082 hasConceptScore W2009588082C143998085 @default.
• W2009588082 hasConceptScore W2009588082C146357865 @default.
• W2009588082 hasConceptScore W2009588082C151730666 @default.
• W2009588082 hasConceptScore W2009588082C2777176818 @default.
• W2009588082 hasConceptScore W2009588082C2777546739 @default.
• W2009588082 hasConceptScore W2009588082C2777757722 @default.
• W2009588082 hasConceptScore W2009588082C2777982462 @default.
• W2009588082 hasConceptScore W2009588082C2778292576 @default.
• W2009588082 hasConceptScore W2009588082C2781467025 @default.
• W2009588082 hasConceptScore W2009588082C3018521938 @default.
• W2009588082 hasConceptScore W2009588082C509974204 @default.
• W2009588082 hasConceptScore W2009588082C530470458 @default.
• W2009588082 hasConceptScore W2009588082C71924100 @default.
• W2009588082 hasConceptScore W2009588082C86803240 @default.
• W2009588082 hasIssue "9" @default.
• W2009588082 hasLocation W20095880821 @default.
• W2009588082 hasLocation W20095880822 @default.
• W2009588082 hasOpenAccess W2009588082 @default.
• W2009588082 hasPrimaryLocation W20095880821 @default.

• next